| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283718A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 02/19/2003 | EP1283714A1 Use of lactobacillus casei in immunostimulatory peptides |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP1283709A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP1283675A1 Methods of modulating the activity of mura |
| 02/19/2003 | EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |
| 02/19/2003 | EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 02/19/2003 | EP1066040B1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| 02/19/2003 | EP0863752B1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 02/19/2003 | EP0817786B1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 02/19/2003 | EP0793484B1 Adjuvant for a vaccine composition |
| 02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 02/19/2003 | EP0774969B1 Hiv protease inhibitor combination |
| 02/19/2003 | EP0750618B1 Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398258A 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 02/19/2003 | CN1398184A Compsns. contg. itraconazole with improved bioavailability and narrow intra-and inter-individual variation of its absorption |
| 02/19/2003 | CN1397563A Process for preparing phytolaccae antivirus protein |
| 02/19/2003 | CN1397562A Derivative of micronomycine and its preparing process and medical application |
| 02/19/2003 | CN1397556A Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 02/19/2003 | CN1397346A Genetically engineered rabies virus vaccine with recombination-defective adenovirus carrier |
| 02/19/2003 | CN1101818C Novel water-soluble c-ring analogues of 20(s)-campothecin |
| 02/19/2003 | CN1101814C Novel hydroxy and polyhydroxy derivatives of coumarin, prepn. thereof and antiviral action thereof |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/19/2003 | CN1101693C Externally applied Chinese medicine |
| 02/19/2003 | CN1101689C anti-infections antipyretic and antalgic medicine |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521612 Antibiotic compounds |
| 02/18/2003 | US6521600 Antimicrobial activity against pathogenic microorganisms; culturing and isolating |
| 02/18/2003 | US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521425 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins |
| 02/18/2003 | US6521423 Intracellular production of Hepatitis C E2 polypeptides |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| 02/18/2003 | US6521415 Tandem immuno-assay for cancer |
| 02/18/2003 | US6521270 Compositions comprising nitrofurantoin and uva ursi |
| 02/18/2003 | US6521262 Solid instant-release forms of administration and process for producing the same |
| 02/18/2003 | US6521248 Cavitation; reduced pressure; oxygenated water |
| 02/18/2003 | US6521236 Vector vaccine of recombinant feline herpesvirus |
| 02/18/2003 | US6521235 Alphavirus RNA replicon systems |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19 |
| 02/17/2003 | CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 02/14/2003 | WO2002018326A1 Novel propenohydroxamic acid derivatives |
| 02/14/2003 | CA2423733A1 Novel propenohydroxamic acid derivatives |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012129A2 Shikimate kinase from s. aureus for drug discovery |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 02/13/2003 | WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/13/2003 | WO2003012078A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 02/13/2003 | WO2003012075A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation |
| 02/13/2003 | WO2003012044A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | WO2003011911A1 Substance specific to pd-1 |
| 02/13/2003 | WO2003011909A1 Binding agents with differential activity |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 02/13/2003 | WO2003011893A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | WO2003011884A1 Process for the preparation of ribavirin |
| 02/13/2003 | WO2003011883A2 Process for the preparation of l-ribavirin |
| 02/13/2003 | WO2003011882A1 4'-substituted leucomycins |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011862A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/13/2003 | WO2003011859A2 Oxazolidinone derivatives as antibacterial agents |
| 02/13/2003 | WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011339A1 Composition for epigallocatechin gallate |
| 02/13/2003 | WO2003011334A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | WO2003011332A1 Methods relating to improved polyepitope vaccination strategies |
| 02/13/2003 | WO2003011331A2 Materials and methods relating to improved vaccination strategies |
| 02/13/2003 | WO2003011329A2 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011314A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | WO2003011310A1 Methods and compositions for control of coccidiosis |
| 02/13/2003 | WO2003011307A1 Use of oversulfated polysaccharides as inhibitors of hiv |
| 02/13/2003 | WO2003011298A1 Antibacterial oxazinones and methods for their use and synthesis |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2003011287A1 Pyrazolon derivatives as inhibitors of gsk-3 |
| 02/13/2003 | WO2003011277A2 Methods to mobilize progenitor/stem cells |
| 02/13/2003 | WO2003011266A2 Azalide antibiotic compositions |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011226A2 Products and drug delivery vehicles |
| 02/13/2003 | WO2003011223A2 Immunomodulatory compounds and methods of use thereof |
| 02/13/2003 | WO2003011221A2 PREPARATION AND USE OF α-KETO PHOSPHONATES |
| 02/13/2003 | WO2003011214A2 Novel methods and formulations for administration of active agents |
| 02/13/2003 | WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 02/13/2003 | WO2003011114A2 Methods for treating prostatitis |
| 02/13/2003 | WO2003011055A1 Nutritional composition preventing bacterial overgrowth |